Norton Rose Fulbright represented Alcon Inc., Latham & Watkins represented LENSAR, Inc. in the transaction. Alcon Inc. (SIX/NYSE: ALC), the global leader in eye care dedicated...
Alcon Inc’s Acquisition of LENSAR Inc
CARGO Therapeutics’ $281.3 Million Initial Public Offering
Wilson Sonsini Goodrich & Rosati and Latham & Watkins advised CARGO Therapeutics, Inc. on the offering, and Cooley advised the underwriters. CARGO Therapeutics, Inc. (CARGO) (Nasdaq:CRGX)...
Silver Lake’s Investment in ProService
Latham & Watkins is representing Silver Lake in the transaction. ProService announced that Silver Lake, a global leader in technology investing, has partnered with the ProService...
Revolution Medicines’ $345 Million Common Stock Public Offering
Latham & Watkins is advising Revolution Medicines on the offering, and Davis Polk is advising the underwriters involved. Revolution Medicines, Inc. (Nasdaq: RVMD) has announced the...